Company / Revenue
PUMA BIOTECHNOLOGY, INC. Revenue History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$235.6M
FY2025
5-year range
$225.1M / $272.3M
FY2021-FY2025
Trend
+3.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has fluctuated over the past 9 years, ranging from $6M in FY2018 to $272M in FY2021.
Based on SEC 10-K filings.
$236M in FY2025 with a 5-year CAGR of -1.3%.
Declined from $253M to $236M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +1.5%
- 5-Year CAGR
- -1.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -1.3%, indicating a declining trend.
- In FY2025, revenue increased 3.3% year-over-year.
- Peak revenue was recorded in FY2021.
- Lowest revenue in the period was in FY2018.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $235.6M | +3.3% |
| FY2024 | $228.0M | -9.9% |
| FY2023 | $253.2M | +12.5% |
| FY2022 | $225.1M | -17.3% |
| FY2021 | $272.3M | +8.5% |
| FY2020 | $251.0M | +806.6% |
| FY2019 | $27.7M | +355.6% |
| FY2018 | $6.1M | -78.0% |
| FY2017 | $27.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026